News Short

Jun 25

0

Sound Pharmaceuticals announces positive topline results from the SPI-1005 Phase 2b Meniere’s Disease clinical trial

By Jim | News Short | No Comments

SPI-1005 hits pre-specified endpoints resulting in a significant improvement in hearing loss of 65% and 95% relative to placebo

Read More

Mar 20

0

Sound Pharmaceuticals announces completion of patient enrollment in the Phase 2b Meniere’s Disease clinical trial

By Jim | News Short | No Comments

Read More

Jan 14

0

Sound Pharmaceuticals advances Phase 2 hearing loss clinical trial in Cystic Fibrosis

By Jim | News Short | No Comments

Read More

Oct 18

0

Sound Pharmaceuticals to Present Preliminary Data on Ototoxicity Study

By Jim | News Short | No Comments

Read More

Nov 01

0

University of Oxford and Sound Pharmaceuticals begin Phase 2 clinical trial on novel treatment for bipolar disorder

By Jim | News Short | No Comments

Read More

Oct 03

0

Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Meniere’s Disease

By Jim | News Short | No Comments

Read More

Sep 29

0

Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by Antibiotics

By Jim | News Short | No Comments

Read More

Jun 29

0

Sound Pharmaceuticals completes enrollment on Meniere’s Disease clinical trial

By Jim | News Short | No Comments

Read More

Mar 20

0

Sound Pharmaceuticals announces $1.6 Million Award from Cystic Fibrosis Foundation Therapeutics to prevent and treat the hearing loss and tinnitus associated with antibiotic use

By Jim | News Short | No Comments

Read More

Nov 01

0

Sound Pharmaceuticals announces two new executive hires to accelerate its Meniere’s drug development program

By Jim | News Short | No Comments

Read More